Active project grants relating to our work in the Medicines Discovery Institute.
|Design and development of AMPA receptor modulators with a much improved safety profile as novel drugs for treating the cognitive dysfunction associated with schizophrenia and other CNS disorders||01/09/2014|
|Wellcome Trust||Ward, Atack||£4,100,000|
|Valium without the sedation: Non-sedating anxiolytic GABAA receptor modulators for the treatment of anxiety disorders||01/06/2016|
|MRC||Atack, Gosling, Ward||£1,800,000|
|α5-GABAA Receptor Modulators for the Treatment of Cognitive Impairment Associated with Huntington’s Disease||01/06/2016|
|Wellcome Trust||Atack, Gosling, Ward||£3,050,000|